[go: up one dir, main page]

DK2897625T3 - Amnionmembran og anvendelse deraf til sårheling og tissue engineering-konstrukter - Google Patents

Amnionmembran og anvendelse deraf til sårheling og tissue engineering-konstrukter Download PDF

Info

Publication number
DK2897625T3
DK2897625T3 DK13834448.6T DK13834448T DK2897625T3 DK 2897625 T3 DK2897625 T3 DK 2897625T3 DK 13834448 T DK13834448 T DK 13834448T DK 2897625 T3 DK2897625 T3 DK 2897625T3
Authority
DK
Denmark
Prior art keywords
wound healing
tissue engineering
amnion membrane
engineering constructs
constructs
Prior art date
Application number
DK13834448.6T
Other languages
English (en)
Inventor
Anthony Atala
Sean V Murphy
Aleksander Skardal
Original Assignee
Univ Wake Forest Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest Health Sciences filed Critical Univ Wake Forest Health Sciences
Application granted granted Critical
Publication of DK2897625T3 publication Critical patent/DK2897625T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C12N2533/92—Amnion; Decellularised dermis or mucosa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Composite Materials (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
DK13834448.6T 2012-09-10 2013-09-10 Amnionmembran og anvendelse deraf til sårheling og tissue engineering-konstrukter DK2897625T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261698960P 2012-09-10 2012-09-10
PCT/US2013/058940 WO2014040026A2 (en) 2012-09-10 2013-09-10 Amniotic membrane and its use in wound healing and tissue engineering constructs

Publications (1)

Publication Number Publication Date
DK2897625T3 true DK2897625T3 (da) 2019-12-16

Family

ID=50237790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13834448.6T DK2897625T3 (da) 2012-09-10 2013-09-10 Amnionmembran og anvendelse deraf til sårheling og tissue engineering-konstrukter

Country Status (5)

Country Link
US (5) US20140342015A1 (da)
EP (1) EP2897625B1 (da)
DK (1) DK2897625T3 (da)
ES (1) ES2756332T3 (da)
WO (1) WO2014040026A2 (da)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11877921B2 (en) 2010-05-05 2024-01-23 Markman Biologics Corporation Method and apparatus for creating a modified tissue graft
US12048617B2 (en) 2010-05-05 2024-07-30 Celltherx Method and apparatus for creating a modified tissue graft
US11701213B2 (en) 2010-05-05 2023-07-18 Markman Biologics Corporation Method and apparatus for creating a modified tissue graft
WO2011159889A2 (en) 2010-06-17 2011-12-22 Washington University Biomedical patches with aligned fibers
ES2756332T3 (es) 2012-09-10 2020-04-27 Univ Wake Forest Health Sciences Membrana amniótica y su uso en cicatrización de heridas y construcciones de ingeniería tisular
IN2015DN02299A (da) 2012-09-21 2015-08-21 Univ Washington
US9155799B2 (en) 2012-11-19 2015-10-13 Mimedx Group, Inc. Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US10029030B2 (en) 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
US9446142B2 (en) * 2013-05-28 2016-09-20 Mimedx Group, Inc. Polymer chelator conjugates
JP6756612B2 (ja) 2013-08-30 2020-09-16 ミメディクス グループ インコーポレイテッド キレーターを含む微粒子化した胎盤性組成物
CA2932271C (en) 2013-12-06 2024-02-06 Allosource Methods of drying sheets of tissue
US9132156B1 (en) * 2014-06-15 2015-09-15 Amnio Technology Llc Acellular amnion derived therapeutic compositions
WO2015175752A1 (en) * 2014-05-14 2015-11-19 NuTech Spine, Inc. Wound care treatment and methods of making and using same
TW201603818A (zh) * 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
WO2016004212A1 (en) * 2014-07-01 2016-01-07 Vicus Therapeutics, Llc Hydrogels for treating and ameliorating wounds and methods for making and using them
JP2017530153A (ja) * 2014-10-02 2017-10-12 ウェイク フォレスト ユニバーシティー ヘルス サイエンシズ 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用
CA2964926C (en) 2014-10-24 2023-05-09 Wake Forest University Health Sciences Tissue-mimicking hydrogel compositions for biofabrication
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
US20160287640A1 (en) * 2014-12-31 2016-10-06 Applied Biologics, Llc Denuded amnion flowable tissue graft and method of forming same
WO2016133887A1 (en) * 2015-02-16 2016-08-25 The University Of Akron Decellularized tissue/nanofiber/hydrogel hybrid material for optimized tissue regeneration
CN107635567A (zh) * 2015-04-17 2018-01-26 加利福利亚大学董事会 用于细胞输送、细胞培养和炎症预防的脱细胞化的人羊膜
WO2016187100A1 (en) 2015-05-15 2016-11-24 The Methodist Hospital System Implantable nanochannel delivery devices
WO2016206703A2 (en) * 2015-06-25 2016-12-29 Science And Technology Development Fund (Stdf) Biomimetic amniotic membrane niche for stem cells
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
US10006003B2 (en) * 2015-06-30 2018-06-26 Surgenex, LLC Compositions and methods for flowable allograft amniotic tissue
CN105536064B (zh) * 2015-12-11 2018-10-26 成都青山利康药业有限公司 一种复合型软组织修复水凝胶及其制备方法和用途
EP3400031A4 (en) 2016-01-08 2019-08-07 CryoLife, Inc. TRANSPLANT PRODUCTS FROM HUMAN PLAZENTA WEAVE, METHOD AND DEVICES
WO2017132464A1 (en) 2016-01-28 2017-08-03 3D Systems, Inc. Methods and apparatus for 3d printed hydrogel materials
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
WO2017136557A1 (en) * 2016-02-05 2017-08-10 Petrucci Gary M Methods and materials for treating nerve injuries and neurological disorders
US10632228B2 (en) 2016-05-12 2020-04-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
CN107441547B (zh) * 2016-05-30 2020-11-20 四川大学华西医院 一种创伤修复材料及其制备方法和用途
US11286231B2 (en) * 2016-10-26 2022-03-29 Wake Forest University Health Sciences Hydrogen-bonding compounds, compositions comprising the same, and methods of preparing and using the same
CN110944654B (zh) * 2017-07-14 2023-09-12 武汉市康创科技有限公司 一种包含脱细胞羊膜的复合膜及其制备方法
US20200268944A1 (en) * 2017-09-15 2020-08-27 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for particulated and reconstituted tissues
US11629329B2 (en) 2017-10-11 2023-04-18 Wake Forest University Health Sciences Bioink compositions and methods of preparing and using the same
CA3116829A1 (en) * 2017-10-17 2019-04-25 The Methodist Hospital System Delivery devices
GB201800909D0 (en) * 2018-01-19 2018-03-07 Biocel Ltd Compositions and methods relating to amnion
EP3746785A4 (en) 2018-02-02 2022-05-11 Wake Forest University Health Sciences, Inc. IMMUNOTHERAPY-RELATED ORGANOIDS AND METHODS OF MANUFACTURE AND USE THEREOF
WO2019200152A1 (en) * 2018-04-13 2019-10-17 Thomas Zarembinski Compositions and methods for the treatment of brain damage
CN111359020B (zh) * 2018-12-26 2022-05-13 深圳兰度生物材料有限公司 软组织修复材料及其制备方法和应用
CN109847088B (zh) * 2019-01-18 2022-04-01 广州润虹医药科技股份有限公司 复合型脱细胞真皮基质生物敷料及其制备方法
PT115689B (pt) * 2019-07-31 2021-10-22 Univ Aveiro Hidrogéis produzidos a partir de membranas fetais humanas, processos e suas aplicações
EP4048298A4 (en) 2019-10-24 2023-11-22 Biopryme Biologics, Inc. Preparation and use of therapeutic hydrogels
US20220249550A1 (en) * 2019-10-24 2022-08-11 Briopryme Biologics, Inc. Preparation and use of tissue matrix derived powder
KR20220134781A (ko) * 2020-02-13 2022-10-05 바켈 에스.알.엘. 천연 중합체에 기반한 패치 제품
CN111330065A (zh) * 2020-03-23 2020-06-26 动之医学技术(上海)有限公司 医用复合纤维、制备方法以及组织修复敷料
CN115916109A (zh) * 2020-03-26 2023-04-04 马克曼生物制品公司 修饰的组织移植物和用于创建修饰的组织移植物的方法和设备
US11918703B2 (en) 2020-08-13 2024-03-05 Universidad De Los Andes Extrudable photocrosslinkable hydrogel and method for its preparation
WO2022140524A1 (en) * 2020-12-22 2022-06-30 The Regents Of The University Of California Amniotic membrane for myocardial repair
CN113274354A (zh) * 2021-04-27 2021-08-20 胡竹林 风干羊膜粉及应用
EP4376908A4 (en) 2021-07-29 2025-05-28 Acera Surgical, Inc. Combined macro and micro-porous hybrid-scale fiber matrix
EP4377502A4 (en) 2021-07-29 2025-05-28 Acera Surgical, Inc. Particle-form hybrid-scale fiber matrix
WO2023039381A1 (en) 2021-09-07 2023-03-16 Acera Surgical, Inc. Materials and methods for nerve repair and regeneration
CN116077717B (zh) * 2021-11-05 2024-01-30 重庆医科大学附属口腔医院 一种用于伤口愈合的生物荷载系统及其应用
EP4201439A1 (en) * 2021-12-23 2023-06-28 Axenoll Life Sciences AG A three-dimensional biocompatible matrix and its uses in wound management
BR102022006759A2 (pt) 2022-04-07 2023-10-17 Tissuelabs Pesquisa E Desenvolvimento Ltda Processos livres de enzimas para produzir uma solução de matriz extracelular tecido-específica, um hidrogel tecido-específico, um produto derivado da solução de matriz extracelular tecido-específica, um pó solúvel tecido-específico e uma membrana tecido-específica, e seus produtos, processos para fornecer compostos bioativos para regenerar tecido, processo in vitro para fornecer compostos bioativos por meio do hidrogel tecido-específico, usos da solução de matriz extracelular tecido-específica, ingrediente aditivo para meio de cultura de células, processo para cultivar células e agregados celulares dentro do hidrogel tecido-específico, processo para bioimprimir biotintas 3d, processo para bioimprimir 3d e kit
CN115227862A (zh) * 2022-04-20 2022-10-25 杭州倍荣生物科技有限公司 治疗用水凝胶敷料的制备与使用
CN115068661B (zh) * 2022-06-21 2023-06-02 杭州倍荣生物科技有限公司 一种海藻酸钙复合多孔生物基质敷料、其制备方法和应用
CN116159187B (zh) * 2022-12-22 2024-10-22 浙江大学 一种引导软硬组织再生修复的一体化口腔修复套装
WO2024171223A1 (en) * 2023-02-16 2024-08-22 Tech Cell Innovations Pvt. Ltd. Freeze dried exosome-based composition and method of preparation thereof
PL451263A1 (pl) * 2025-02-21 2025-11-24 Śląski Uniwersytet Medyczny W Katowicach Sposób otrzymywania jednorodnych homogenatów błony owodniowej
CN120478732A (zh) * 2025-06-25 2025-08-15 山东省泉港生物技术有限公司 一种交联的羊膜脱细胞基质填充材料及其制备方法
CN120837429A (zh) * 2025-09-24 2025-10-28 湖南格致生物科技有限公司 一种羊膜水凝胶的制备方法及羊膜水凝胶

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001944A (en) 1975-08-25 1977-01-11 Parke, Davis & Company Freeze-drying process
US5514378A (en) 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
EP1079749A1 (en) * 1998-05-23 2001-03-07 Focal, Inc. Method of treatment for premature rupture of membranes in pregnancy (prom)
US20040048798A1 (en) * 1999-06-01 2004-03-11 Raitano Arthur B. Nucleic acid and corresponding protein entitle 98P4B6 useful in treatment and detection of cancer
WO2000041732A1 (en) 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
WO2003024496A1 (en) * 2001-09-05 2003-03-27 Hans Biomed Corporation A process for preparing a biomaterial for tissue repair
US20100254900A1 (en) * 2002-03-18 2010-10-07 Campbell Phil G Biocompatible polymers and Methods of use
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
EP1549328A4 (en) * 2002-09-18 2009-07-08 Emiliano Ghinelli USE OF A HUMAN SHEEP SKIN COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF DISEASES AND STATES OF EYE AND SKIN
KR20050092795A (ko) * 2003-01-31 2005-09-22 짐머 오르쏘바이올로직스 인코포레이티드 수핵 조직을 함유하는 하이드로젤 조성물
US20080039940A1 (en) 2004-03-11 2008-02-14 Kouji Hashimoto Biological Tissue Sheet, Method Of Forming The Same And Transplantation Method By Using The Sheet
ATE464855T1 (de) * 2004-03-31 2010-05-15 Cook Inc Transplantatmaterial und gefässprothese mit extrazellulärer kollagenmatrix und dessen herstellungsverfahren
US7968085B2 (en) * 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
AU2005308920B2 (en) * 2004-11-29 2010-04-15 Dsm Ip Assets B.V. Method for reducing the amount of migrateables of polymer coatings
WO2006094247A2 (en) * 2005-03-02 2006-09-08 Tissuetech, Inc. Amniotic membrane extracts, compositions thereof, and methods of use
US8182841B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-inflammation methods
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
US8071135B2 (en) * 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
CA2665369C (en) 2006-10-06 2023-01-10 Anthrogenesis Corporation Human placental collagen compositions, and methods of making and using the same
US8709081B2 (en) * 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
EP2197270B8 (en) 2007-09-07 2020-03-04 Surgical Biologics, LLC Placental tissue grafts and improved methods of preparing and using the same
WO2009134414A2 (en) * 2008-04-30 2009-11-05 The Board Of Trustees Of The Leland Stanford Junior University Devices for the treatment of wounds and methods and kits thereof
US20110219462A1 (en) 2008-07-15 2011-09-08 Bayer Schering Pharma Aktiengesellschaft G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases
EP2341953B1 (en) * 2008-09-04 2018-11-21 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
US9121007B2 (en) * 2010-01-26 2015-09-01 Anthrogenesis Corporatin Treatment of bone-related cancers using placental stem cells
KR101132625B1 (ko) * 2010-02-03 2012-04-02 주식회사 바이오랜드 콘택트 렌즈 형태의 양막 드레싱의 제조 방법
EP2536825B1 (en) 2010-02-18 2024-03-27 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
WO2012170905A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
US9931423B2 (en) 2011-08-26 2018-04-03 Tissuetech, Inc. Methods of sterilizing fetal support tissues
US9585983B1 (en) 2011-10-12 2017-03-07 BioDlogics, LLC Wound covering and method of preparation
US8932805B1 (en) 2011-10-31 2015-01-13 BioDlogics, LLC Birth tissue material and method of preparation
EP2785360B1 (en) 2011-12-02 2019-06-19 MIMEDX Group Inc. Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using same
JP6254094B2 (ja) 2011-12-22 2017-12-27 ミメディクス グループ インコーポレイテッド 架橋脱水された胎盤組織移植片ならびにそれを作製および使用する方法
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
ES2756332T3 (es) 2012-09-10 2020-04-27 Univ Wake Forest Health Sciences Membrana amniótica y su uso en cicatrización de heridas y construcciones de ingeniería tisular
CA2826786A1 (en) 2012-09-17 2014-03-17 Confluent Surgical, Inc. Multi-encapsulated formulations made with oxidized cellulose
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
CA2894160C (en) 2012-12-07 2024-01-02 Anthrogenesis Corporation Treating oral lesions using placental extracellular matrix
US9292045B2 (en) * 2013-02-15 2016-03-22 Apple Inc. Apparatus and method for automatically activating a camera application based on detecting an intent to capture a photograph or a video
US9814746B2 (en) 2014-06-15 2017-11-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
EP3191145B1 (en) 2014-09-09 2020-12-23 MiMedx Group, Inc. Micronized placental tissue compositions
CA2964163A1 (en) 2014-11-05 2016-05-12 Tissuetech, Inc. Compositions and method for promoting nerve growth and regeneration
JP2018516869A (ja) 2015-05-20 2018-06-28 ティッシュテック，インク． 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法

Also Published As

Publication number Publication date
EP2897625A2 (en) 2015-07-29
US20140342015A1 (en) 2014-11-20
US20240398873A1 (en) 2024-12-05
EP2897625B1 (en) 2019-10-23
ES2756332T3 (es) 2020-04-27
US10967009B2 (en) 2021-04-06
US10016464B2 (en) 2018-07-10
EP2897625A4 (en) 2016-08-17
WO2014040026A2 (en) 2014-03-13
US20220016179A1 (en) 2022-01-20
US20190111088A1 (en) 2019-04-18
WO2014040026A3 (en) 2015-07-23
US20140348940A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
DK2897625T3 (da) Amnionmembran og anvendelse deraf til sårheling og tissue engineering-konstrukter
DK2931143T3 (da) Implantat og føring til kæbe-ansigts-kirurgi
DK3200809T3 (da) Amniotisk membranpulver og dets anvendelse ved sårheling og vævsteknikkonstruktioner
DK2925782T3 (da) Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf
DK3019483T3 (da) Terapeutiske aktive forbindelser og fremgangsmåder til deres anvendelse
DK2844672T3 (da) Humane antistoffer over for Fel d1 og fremgangsmåder til anvendelse deraf
DK3351239T3 (da) Prostamid-indeholdende intraokulære implantater og fremgangsmåder til anvendelse deraf
DK3550836T3 (da) Fremgangsmåde og anordning til afkodning
DK2720617T4 (da) Vævsbeholder / beholderaggregat og dertil knyttet fremgangsmåde.
DK2579877T3 (da) Morpholinopyrimidiner og deres anvendelse til terapi
DK2917763T3 (da) Lidar-målesystem og lidar-målefremgangsmåde
CO6930321A2 (es) Curación de tejidos
DK2854883T3 (da) Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf
DK2928533T3 (da) Medicinske slanger og fremgangsmåder til fremstilling
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
BR112013018469A2 (pt) dispositivos e métodos para tratamento de tecidos
DK2683731T3 (da) C4-monomethyl-triterpenoidderivater og fremgangsmåder til anvendelse deraf
BR112014005914A2 (pt) Produto para cicatrização de feridas tecidulares
DK2994173T3 (en) Wound healing and tissue engineering
DK2918339T3 (da) Hydrogeneringskatalysator og fremgangsmåde til fremstilling deraf og anvendelse deraf
BR112014033045A2 (pt) dispositivo e método para ligação de tecido
DK2764881T3 (da) System til medicinsk behandling
BR112013023743A2 (pt) anticorpo de fator de tecidos humanos e usos do mesmo
DK2950764T3 (da) Sårhage/stabilisator til overskydende og/eller overflødigt væv
DK2964767T3 (da) Toksingener og fremgangsmåder til anvendelse deraf